See more : Domtar Corporation (UFS) Income Statement Analysis – Financial Results
Complete financial analysis of Fortrea Holdings Inc. (FTRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fortrea Holdings Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Banco de Valores S.A. (VALO.BA) Income Statement Analysis – Financial Results
- Chongqing Changan Automobile Company Limited (200625.SZ) Income Statement Analysis – Financial Results
- Companhia de Tecidos Norte de Minas (CTNM4.SA) Income Statement Analysis – Financial Results
- Stella Diagnostics Inc. (SLDX) Income Statement Analysis – Financial Results
- Simon Property Group Acquisition Holdings, Inc. (SPGS) Income Statement Analysis – Financial Results
Fortrea Holdings Inc. (FTRE)
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 3.11B | 3.10B | 3.06B | 2.58B |
| Cost of Revenue | 2.69B | 2.47B | 2.45B | 2.09B |
| Gross Profit | 424.00M | 621.70M | 604.40M | 489.10M |
| Gross Profit Ratio | 13.64% | 20.08% | 19.77% | 18.96% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 336.60M | 299.90M | 303.10M | 267.60M |
| Other Expenses | 0.00 | 7.00M | 1.90M | 800.00K |
| Operating Expenses | 457.30M | 396.20M | 469.40M | 386.60M |
| Cost & Expenses | 3.05B | 2.87B | 2.92B | 2.48B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 69.80M | 132.40M | 200.00K | 0.00 |
| Depreciation & Amortization | 96.40M | 117.60M | 198.80M | 156.40M |
| EBITDA | 166.90M | 354.60M | 335.20M | -175.80M |
| EBITDA Ratio | 5.37% | 10.62% | 9.87% | 25.46% |
| Operating Income | 63.10M | 185.20M | 114.30M | -314.20M |
| Operating Income Ratio | 2.03% | 5.98% | 3.74% | -12.18% |
| Total Other Income/Expenses | -62.00M | 1.10M | 22.10M | -434.70M |
| Income Before Tax | 1.10M | 58.90M | 136.40M | -332.20M |
| Income Before Tax Ratio | 0.04% | 1.90% | 4.46% | -12.87% |
| Income Tax Expense | 4.50M | 500.00K | 38.40M | 27.00M |
| Net Income | -3.40M | 58.40M | 98.00M | -359.20M |
| Net Income Ratio | -0.11% | 1.89% | 3.21% | -13.92% |
| EPS | -0.04 | 0.66 | 1.11 | -4.06 |
| EPS Diluted | -0.04 | 0.64 | 1.11 | -4.06 |
| Weighted Avg Shares Out | 88.80M | 88.40M | 88.40M | 88.40M |
| Weighted Avg Shares Out (Dil) | 88.80M | 91.10M | 88.40M | 88.40M |
Fortrea to Present at the Evercore HealthCONx Conference
Fortrea to Present at the Citi Global Healthcare Conference
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
Fortrea Holdings, Inc. (FTRE) Q3 2024 Earnings Call Transcript
Fortrea Holdings Inc. (FTRE) Lags Q3 Earnings Estimates
Fortrea Reports Third Quarter 2024 Results
Source: https://incomestatements.info
Category: Stock Reports